The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level.

hormone therapy lymph node metastasis prostate cancer (pca) radiotherapy (rt) spontaneous remission

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
May 2022
Historique:
accepted: 25 05 2022
entrez: 1 7 2022
pubmed: 2 7 2022
medline: 2 7 2022
Statut: epublish

Résumé

The incidence rate of spontaneous remission of malignant cancer is very low. Reports on spontaneous remission in advanced prostate cancer are extremely limited. Our patient was treated with androgen deprivation therapy, local radiotherapy, and surgical castration at the initial diagnosis. Approximately nine years after treatment, he experienced a rise in serum prostate-specific antigen level and relapse of obturator lymph node adenopathy. Initially, androgen deprivation therapy was reinitiated, which resulted in castration-resistant prostate cancer. Although androgen deprivation therapy was discontinued, spontaneous remission of recurrent lymph node and spontaneous reduction in serum prostate-specific antigen level was seen. There was no sign of radiological recurrence for over eight years without prostate cancer treatment.

Identifiants

pubmed: 35774690
doi: 10.7759/cureus.25333
pmc: PMC9236640
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e25333

Informations de copyright

Copyright © 2022, Katano et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Scand J Urol. 2015 Dec;49(6):440-445
pubmed: 26139461
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Prostate Cancer Prostatic Dis. 2008;11(2):198-202
pubmed: 17519924
Intern Med. 2021 Dec 1;60(23):3817-3821
pubmed: 34148955
Sci Rep. 2020 Apr 1;10(1):5743
pubmed: 32238836
Can Urol Assoc J. 2017 Jul;11(7):E315-E317
pubmed: 28761595
Oncol Lett. 2013 Aug;6(2):590-594
pubmed: 24137376
Transl Oncol. 2021 Sep;14(9):101166
pubmed: 34242964
Int J Urol. 2018 Mar;25(3):220-231
pubmed: 29266472
Przegl Lek. 2007;64(4-5):380-2
pubmed: 17724923
Nat Commun. 2020 Mar 23;11(1):1523
pubmed: 32251286
Eur Urol. 2020 Jan;77(1):24-35
pubmed: 31495749
Int J Mol Sci. 2021 Aug 07;22(16):
pubmed: 34445231
Hawaii Med J. 2000 Oct;59(10):379-87
pubmed: 11789163
Can Urol Assoc J. 2010 Dec;4(6):380-4
pubmed: 21191494
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):
pubmed: 29311132

Auteurs

Atsuto Katano (A)

Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Masanari Minamitani (M)

Radiation Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, JPN.

Keiichi Nakagawa (K)

Radiation Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, JPN.

Hideomi Yamashita (H)

Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Classifications MeSH